Agenus proposes 1-for-20 reverse stock split to regain Nasdaq $1 compliance

AGENUS INC

Reverse stock split at 1:20 ratio proposed to lift share price above $1 Nasdaq minimum.
Special shareholder meeting set for April 3, 2024 to vote on the split.
Company plans BLA submission for metastatic colorectal cancer with potential 2025 launch.
Also exploring monetization of royalty assets and real estate to strengthen finances.
Engaged in discussions with pharmaceutical companies for potential cash infusions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.